Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
16.7%
% of WDNA's 90 holdings also in CNCR
21.9%
% of CNCR's 64 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.6% | 1.7% | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% | 1.5% | 1.5% |
 |
BIONTECH SE SPONSORED ADR | 1.3% | 1.8% | 1.3% |
|
REGENERON PHARMACEUTICALS | 1.2% | 1.5% | 1.2% |
|
MERCK & CO. INC. | 1.1% | 1.5% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to CNCR
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
VERACYTE INC | 2.1% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
GILEAD SCIENCES INC | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
WDNA Underweight Relative to CNCR
|
SUMMIT THERAPEUTICS INC | -2.2% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -1.8% |
|
2SEVENTY BIO, INC. | -1.8% |
|
ARVINAS, INC. | -1.8% |
|
Y-MABS THERAPEUTICS, INC. | -1.8% |
|
EXELIXIS INC | -1.8% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -1.7% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
JANUX THERAPEUTICS, INC. | -1.7% |
|
NUVALENT, INC. CLASS A | -1.7% |